Gene expression profiling in early breast cancer treated with neoadjuvant ribociclib plus letrozole (R+L) versus chemotherapy (CT): A correlative analysis of the SOLTI-1402/CORALLEEN phase II trial
T. Pascual1, A.M. Antunes De Melo e Oliveira2, E.M. Ciruelos3, M. Bellet Ezquerra4, C. Saura Manich4, J. Gavila Gregori5, S. Pernas Simon6, M. Muñoz7, M.J. Vidal7, M. Margeli Vila8, J.M. Cejalvo9, B. González-Farré10, M. Espinosa-Bravo11, J.M. Ferrero-Cafiero12, P. Villagrasa12, A. Prat7
Communication in congress
Mini oral presentation
ESMO BREAST
2020
